Determination of Serum Myeloperoxidase (MPO) and lactate dehydrogenase (LDH) as a tumour Marker in Chronic Myeloid Leukaemia (CML)
Objective: To evaluate the efficacy of serum myeloperoxidase and lactate dehydrogenase levels as tumour markers in chronic myeloid leukaemia patients after one-year treatment with tyrosine kinase inhibitors. Method: The case-control study was conducted at the College of Medicine, Mustansiriyah Univ...
Saved in:
| Main Authors: | Khitam Abdul Wahhab Ali, Abeer Anwer Ahmed, Suhad Taha Mohammed |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pakistan Medical Association
2024-09-01
|
| Series: | Journal of the Pakistan Medical Association |
| Online Access: | https://jpma.org.pk/index.php/public_html/article/view/21881 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role and clinical significance of myeloperoxidase (MPO) and TNF-α in prognostic evaluation of T-COPD
by: E. Jiang, et al.
Published: (2025-04-01) -
Lactate Dehydrogenase-A-Forming LDH5 Promotes Breast Cancer Progression
by: Fang T, et al.
Published: (2025-02-01) -
D-Dimer, ferritin, and lactate dehydrogenase (LDH) as predictors of mortality in hospitalized COVID-19 patients
by: Fierna D Hanafi, et al.
Published: (2024-09-01) -
Correlation of serum lactate dehydrogenase (LDH) level with feto-maternal outcome in normal pregnancy and preeclamptic disorders
by: Rupali Modak, et al.
Published: (2024-05-01) -
The role of lactate dehydrogenase (LDH) and vascular endothelial growth factor (VEGF) in nasopharyngeal cancer: a literature review
by: Mochammad Alfian Sulaksana, et al.
Published: (2025-08-01)